» Articles » PMID: 35540797

Assessment of the Genotoxicity of Acrylamide

Overview
Journal EFSA J
Date 2022 May 11
PMID 35540797
Authors
Affiliations
Soon will be listed here.
Abstract

EFSA was requested to deliver a statement on a recent publication revisiting the evidence for genotoxicity of acrylamide (AA). The statement was prepared by a Working Group and was endorsed by the CONTAM Panel before its final approval. In interpreting the Terms of Reference, the statement considered the modes of action underlying the carcinogenicity of AA including genotoxic and non-genotoxic effects. Relevant publications since the 2015 CONTAM Panel Opinion on AA in food were reviewed. Several new studies reported positive results on the clastogenic and mutagenic properties of AA and its active metabolite glycidamide (GA). DNA adducts of GA were induced by AA exposure in experimental animals and have also been observed in humans. In addition to the genotoxicity of AA, there is evidence for both secondary DNA oxidation via generation of reactive oxygen species and for non-genotoxic effects which may contribute to carcinogenesis by AA. These studies extend the information assessed by the CONTAM Panel in its 2015 Opinion, and support its conclusions. That Opinion applied the margin of exposure (MOE) approach, as recommended in the EFSA Guidance for substances that are both genotoxic and carcinogenic, for risk characterisation of the neoplastic effects of AA. Based on the new data evaluated, the MOE approach is still considered appropriate, and an update of the 2015 Opinion is not required at the present time.

Citing Articles

Estimation of the Dietary Acrylamide Exposure of the Turkish Population: An Emerging Threat for Human Health.

Basaran B Nutrients. 2024; 16(18).

PMID: 39339688 PMC: 11434696. DOI: 10.3390/nu16183088.


Dietary Exposure to Acrylamide Has Negative Effects on the Gastrointestinal Tract: A Review.

Palus K Nutrients. 2024; 16(13).

PMID: 38999779 PMC: 11243272. DOI: 10.3390/nu16132032.


Internal exposure to heat-induced food contaminants in omnivores, vegans and strict raw food eaters: biomarkers of exposure to acrylamide (hemoglobin adducts, urinary mercapturic acids) and new insights on its endogenous formation.

Monien B, Bergau N, Gauch F, Weikert C, Abraham K Arch Toxicol. 2024; 98(9):2889-2905.

PMID: 38819476 PMC: 11324683. DOI: 10.1007/s00204-024-03798-z.


Results of the BfR MEAL Study: Acrylamide in foods from the German market with highest levels in vegetable crisps.

Perestrelo S, Schwerbel K, Hessel-Pras S, Schafer B, Kaminski M, Lindtner O Food Chem X. 2024; 22:101403.

PMID: 38694545 PMC: 11061253. DOI: 10.1016/j.fochx.2024.101403.


An exploratory study to assess the knowledge, attitudes and practices of Lebanese residents towards acrylamide.

Kalash N, Kharroubi S, Ballout R, Saleh F PLoS One. 2024; 19(4):e0300617.

PMID: 38625973 PMC: 11020536. DOI: 10.1371/journal.pone.0300617.


References
1.
Benford D, Halldorsson T, Jeger M, Knutsen H, More S, Naegeli H . Guidance on Uncertainty Analysis in Scientific Assessments. EFSA J. 2020; 16(1):e05123. PMC: 7009727. DOI: 10.2903/j.efsa.2018.5123. View

2.
Uchida K . Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med. 2000; 9(5):109-13. DOI: 10.1016/s1050-1738(99)00016-x. View

3.
Goempel K, Tedsen L, Ruenz M, Bakuradze T, Schipp D, Galan J . Biomarker monitoring of controlled dietary acrylamide exposure indicates consistent human endogenous background. Arch Toxicol. 2017; 91(11):3551-3560. PMC: 5696489. DOI: 10.1007/s00204-017-1990-1. View

4.
Komiya M, Ishigamori R, Naruse M, Ochiai M, Miyoshi N, Imai T . Establishment of Novel Genotoxicity Assay System Using Murine Normal Epithelial Tissue-Derived Organoids. Front Genet. 2021; 12:768781. PMC: 8638810. DOI: 10.3389/fgene.2021.768781. View

5.
Manjanatha M, Aidoo A, Shelton S, Bishop M, McDaniel L, Lyn-Cook L . Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice. Environ Mol Mutagen. 2005; 47(1):6-17. DOI: 10.1002/em.20157. View